Meeting
2016 ASCO Annual Meeting
Comparison of outcomes following recurrence or metastasis in HPV+ and HPV- oropharyngeal carcinoma treated with definitive chemoradiation using IMRT.
Authors
Jonathan Eric Leeman
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
Jonathan Eric Leeman , Jin-Gao Li , Praveen Venigalla , Zachary Stephan Zumsteg , Sean Matthew McBride , Jay Boyle , Benjamin R Roman , Eric Jeffrey Sherman , Nancy Y. Lee , Nadeem Riaz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6063)
DOI
10.1200/JCO.2016.34.15_suppl.6063
Abstract #
6063
Poster Bd #
385
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
HPV ctDNA analysis in unresectable recurrent/metastatic oropharyngeal cancer.
First Author: Catherine T Haring
Poster
2014 ASCO Annual Meeting
Patterns of distant metastases in HPV-positive head and neck squamous cell carcinoma.
First Author: Jennie York Law
Poster
2024 ASCO Annual Meeting
Neoadjuvant immunotherapy for oropharynx cancer: Correlative studies and long-term outcomes from the CIAO trial.
First Author: Daniel McGrail
Poster
2023 ASCO Annual Meeting
Randomized phase I/II trial of TheraT vectors expressing HPV16 specific antigens with neoadjuvant chemotherapy followed by transoral robotic surgery (TORS) or risk/response stratified chemoradiotherapy (CRT) for locoregional HPV16+ oropharyngeal cancer (OPC).
First Author: Ari Rosenberg